Obrocea Mihail 4
4 · MAIA Biotechnology, Inc. · Filed Sep 20, 2022
Insider Transaction Report
Form 4
Obrocea Mihail
Chief Medical Officer
Transactions
- Award
Stock Options
2022-09-16+100,000→ 100,000 totalExercise: $3.56Exp: 2032-09-16→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The stock options, granted on September 16, 2022 pursuant to MAIA Biotechnology, Inc.'s 2021 Equity Incentive Plan, representing the right to buy shares of common stock, vest on a 4-year vesting schedule, with 25% of the options to vest on the first anniversary of the date of grant and the remaining options to vest ratably monthly thereafter for 36 months.